• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素(1,7-双-(4-羟基-3-甲氧基苯基)-1,6-庚二烯-3,5-二酮)在大鼠体内的代谢与排泄

The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat.

作者信息

Holder G M, Plummer J L, Ryan A J

出版信息

Xenobiotica. 1978 Dec;8(12):761-8. doi: 10.3109/00498257809069589.

DOI:10.3109/00498257809069589
PMID:726520
Abstract

Curcumin labelled with deuterium and tritium was prepared. Oral and intraperitoneal doses of [3H]curcumin led to the faecal excretion of most of the radioactivity. 2. Intravenous and intraperitoneal doses of [3H]curcumin were well excreted in the bile of cannulated rats. 3. The major biliary metabolites were glucuronides of tetrahydrocurcumin and hexahydrocurcumin. A minor biliary metabolite was dihydroferulic acid together with traces of ferulic acid. Metabolites were identified using chemical ionization mass spectrometry.

摘要

制备了用氘和氚标记的姜黄素。口服和腹腔注射剂量的[3H]姜黄素导致大部分放射性物质经粪便排出。2. 静脉注射和腹腔注射剂量的[3H]姜黄素在插管大鼠的胆汁中排泄良好。3. 主要的胆汁代谢产物是四氢姜黄素和六氢姜黄素的葡糖醛酸苷。一种次要的胆汁代谢产物是二氢阿魏酸以及痕量的阿魏酸。使用化学电离质谱法鉴定代谢产物。

相似文献

1
The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat.姜黄素(1,7-双-(4-羟基-3-甲氧基苯基)-1,6-庚二烯-3,5-二酮)在大鼠体内的代谢与排泄
Xenobiotica. 1978 Dec;8(12):761-8. doi: 10.3109/00498257809069589.
2
Metabolism of curcumin--studies with [3H]curcumin.姜黄素的代谢——用[3H]姜黄素进行的研究
Toxicology. 1981;22(4):337-44. doi: 10.1016/0300-483x(81)90027-5.
3
Urinary and biliary metabolites of mephentermine in male Wistar rats.
Xenobiotica. 1989 Mar;19(3):287-99. doi: 10.3109/00498258909042274.
4
Microbial metabolism. Part 7 : Curcumin.微生物代谢。第7部分:姜黄素。
Nat Prod Res. 2007 May;21(5):444-50. doi: 10.1080/14786410601082144.
5
Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.化学预防剂姜黄素在人及大鼠肝细胞中以及大鼠体内的代谢产物表征,及其抑制佛波酯诱导的前列腺素E2生成能力的评估。
Cancer Res. 2001 Feb 1;61(3):1058-64.
6
A study on the fate of curcumin in the rat.
Acta Pharmacol Toxicol (Copenh). 1978 Aug;43(2):86-92. doi: 10.1111/j.1600-0773.1978.tb02240.x.
7
Absorption and tissue distribution of curcumin in rats.
Toxicology. 1980;16(3):259-65. doi: 10.1016/0300-483x(80)90122-5.
8
Characterization of metabolites of benz(j)aceanthrylene in faeces, urine and bile from rat.大鼠粪便、尿液和胆汁中苯并(j)刺蒽代谢物的表征
Xenobiotica. 1999 Dec;29(12):1257-72. doi: 10.1080/004982599237921.
9
Synthesis and Bioconversion of Curcumin Analogs.姜黄素类似物的合成与生物转化。
Nat Prod Commun. 2017 Apr;12(4):559-562.
10
Curcumin and its analogues as potent inhibitors of low density lipoprotein oxidation: H-atom abstraction from the phenolic groups and possible involvement of the 4-hydroxy-3-methoxyphenyl groups.姜黄素及其类似物作为低密度脂蛋白氧化的有效抑制剂:酚基团的氢原子提取以及4-羟基-3-甲氧基苯基基团的可能参与。
Free Radic Biol Med. 2006 Feb 1;40(3):526-35. doi: 10.1016/j.freeradbiomed.2005.09.008. Epub 2005 Nov 10.

引用本文的文献

1
Advancements in curcuminoid formulations: An update on bioavailability enhancement strategies curcuminoid bioavailability and formulations.姜黄素类制剂的进展:生物利用度提高策略、姜黄素类生物利用度及制剂的最新情况
Open Life Sci. 2025 Jul 18;20(1):20251112. doi: 10.1515/biol-2025-1112. eCollection 2025.
2
Correction of a Traffic-Defective Missense ABCB11 Variant Responsible for Progressive Familial Intrahepatic Cholestasis Type 2.纠正导致2型进行性家族性肝内胆汁淤积症的交通缺陷错义ABCB11变体。
Int J Mol Sci. 2025 May 29;26(11):5232. doi: 10.3390/ijms26115232.
3
Unlocking the Potential of Aqueous Extract in Stress Resistance and Extending Lifespan in .
释放水提取物在抗逆性及延长……寿命方面的潜力
Molecules. 2025 Apr 8;30(8):1668. doi: 10.3390/molecules30081668.
4
Theranostic nanoemulsions suppress macrophage-mediated acute inflammation in rats.诊疗纳米乳剂可抑制大鼠体内巨噬细胞介导的急性炎症。
J Nanobiotechnology. 2025 Feb 4;23(1):80. doi: 10.1186/s12951-025-03164-w.
5
Advances of curcumin in nervous system diseases: the effect of regulating oxidative stress and clinical studies.姜黄素在神经系统疾病中的研究进展:调节氧化应激的作用及临床研究
Front Pharmacol. 2024 Nov 1;15:1496661. doi: 10.3389/fphar.2024.1496661. eCollection 2024.
6
Comparative Pharmacokinetics and Tissue Distribution of Hexahydrocurcumin Following Intraperitoneal vs Oral Administration in Mice Using LC-MS/MS.使用液相色谱-质谱联用(LC-MS/MS)法比较六氢姜黄素在小鼠腹腔注射与口服给药后的药代动力学和组织分布
ACS Omega. 2024 Sep 19;9(39):41032-41042. doi: 10.1021/acsomega.4c06604. eCollection 2024 Oct 1.
7
COVID-19-Associated Sepsis: Potential Role of Phytochemicals as Functional Foods and Nutraceuticals.COVID-19 相关性败血症:植物化学物质作为功能性食品和营养保健品的潜在作用。
Int J Mol Sci. 2024 Aug 3;25(15):8481. doi: 10.3390/ijms25158481.
8
Evaluation of Cross-Talk and Alleviate Potential of Cytotoxic Factors Induced by Deoxynivalenol in IPEC-J2 Cells Interference with Curcumin.姜黄素对脱氧雪腐镰刀菌烯醇诱导的 IPEC-J2 细胞细胞因子间串扰及潜在细胞毒性的干预作用评价。
Int J Mol Sci. 2024 Jun 26;25(13):6984. doi: 10.3390/ijms25136984.
9
Enhancing the Bioavailability and Bioactivity of Curcumin for Disease Prevention and Treatment.提高姜黄素的生物利用度和生物活性以预防和治疗疾病。
Antioxidants (Basel). 2024 Mar 8;13(3):331. doi: 10.3390/antiox13030331.
10
Pharmacological Mechanisms and Clinical Applications of Curcumin: Update.姜黄素的药理机制与临床应用:最新进展
Aging Dis. 2023 Jun 1;14(3):716-749. doi: 10.14336/AD.2022.1101.